NEO NEOGENOMICS INC

Overview and Growth

NEOGENOMICS INC generated $727.33M of revenue in fiscal 2025, with net loss of $108.03M and an operating cash inflow of $5.23M. The $727.33M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 10.1% above fiscal 2024 revenue of $660.57M, marking a year-over-year increase. Total assets stood at $1.36B, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Asset turnover was 0.53x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

After reported cost of revenue, the company retained $314.29M as gross profit before recognizing operating expenses and other items. Gross profit represented 43.2% of revenue, showing how much of the top line remained after direct costs. The company recorded an operating loss of $115.88M after the reported operating expense base. Relative to revenue, the operating deficit measured 15.9%, showing the shortfall after operating costs. After all below-operating-line items, the company recorded a net loss of $108.03M for the fiscal year. Net margin was -14.9%, reflecting a loss equal to 14.9% of reported revenue. The pretax result was a loss of $110.27M, establishing the deficit before tax effects. Pretax margin was -15.2%, reflecting a pre-tax loss equal to 15.2% of revenue. The company recognized an income-tax benefit of $2.24M, increasing after-tax earnings relative to the pretax result. The net loss equaled 12.9% of period-end equity, showing the deficit relative to book capital. The net loss equaled 7.9% of period-end assets, showing the deficit relative to the asset base. Compared with a $78.73M net loss in fiscal 2024, the current loss increased to $108.03M.

Liquidity and Capital Structure

Total assets were $1.36B, supported by $523.27M of liabilities and $836.56M of shareholder equity. At period end, current assets of $376.29M compared with current liabilities of $88.30M, defining the company’s short-term resource position. Current assets covered current liabilities by 4.26x, leaving a positive buffer for near-term obligations. Reported cash and equivalents were $159.62M, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 180.8% of current liabilities, showing how much near-term coverage came from cash alone. Total debt was $341.86M, establishing the amount of borrowing carried within the company’s capital structure. The debt-to-equity relationship was 0.41x, showing how much debt the company carried for each unit of book equity. Debt represented 25.1% of total assets, placing borrowing in the context of the company’s full resource base. Liabilities represented 38.5% of total assets, quantifying the liability-funded share of the company’s resource base. Measured against total assets, cash and equivalents represented 11.7%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 17.0% lower than fiscal 2024 assets of $1.64B, measuring the company’s own balance-sheet change. Book equity was 7.3% lower than fiscal 2024 equity of $902.34M, showing how shareholder capital changed year over year. The reported cash balance changed 56.5% from $367.01M in fiscal 2024, ending lower year over year.

Cash Flow and Earnings Quality

Cash flow from operations was $5.23M, a reported cash inflow that can be compared directly with net income and capital spending. Capital expenditures used $27.01M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Capital expenditures represented 516.4% of operating cash flow, leaving the remainder available as free cash flow. Operating cash flow and capital spending combined to leave a $21.78M cash deficit after capital spending. The free-cash-flow deficit equaled 3.0% of revenue, showing the post-investment cash shortfall relative to sales. Relative to total assets, the post-investment cash deficit measured 1.6%.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.